Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Inhibition of myostatin reverses muscle fibrosis through apoptosis.

Bo Li Z, Zhang J, Wagner KR.

J Cell Sci. 2012 Sep 1;125(Pt 17):3957-65. doi: 10.1242/jcs.090365. Epub 2012 Jun 8.

2.

Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy.

Amthor H, Hoogaars WM.

Curr Gene Ther. 2012 Jun;12(3):245-59. Review.

PMID:
22554312
3.

Myostatin/activin pathway antagonism: molecular basis and therapeutic potential.

Han HQ, Zhou X, Mitch WE, Goldberg AL.

Int J Biochem Cell Biol. 2013 Oct;45(10):2333-47. doi: 10.1016/j.biocel.2013.05.019. Epub 2013 May 28. Review.

PMID:
23721881
4.

INVITED REVIEW: Inhibitors of myostatin as methods of enhancing muscle growth and development.

Chen PR, Lee K.

J Anim Sci. 2016 Aug;94(8):3125-3134. Review.

PMID:
27695802
5.

Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease.

Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR.

Muscle Nerve. 2009 Mar;39(3):283-96. doi: 10.1002/mus.21244. Review.

6.

Regenerative pharmacology in the treatment of genetic diseases: the paradigm of muscular dystrophy.

Mozzetta C, Minetti G, Puri PL.

Int J Biochem Cell Biol. 2009 Apr;41(4):701-10. doi: 10.1016/j.biocel.2008.08.033. Epub 2008 Sep 2. Review.

7.

Macrophages decide between regeneration and fibrosis in muscle.

Muñoz-Cánoves P, Serrano AL.

Trends Endocrinol Metab. 2015 Sep;26(9):449-50. doi: 10.1016/j.tem.2015.07.005. Epub 2015 Aug 4. Review.

PMID:
26250053

Supplemental Content

Support Center